Among 348 altered genes, Vimentin and Tgf-β2 were significantly reduced (Figure 4A), as well as genes involved in TGF-β signaling pathways which are the main mediators of cancer EMT (Figure 4B). This evidence concerns the gene TGFB2 and cancer.